$REFR
RESEARCH FRONTIERS INC Stock $refr

$refr Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-K Financial Statement

#000120677414000818 Filed on March 10, 2014

Income Statement

Concept	2014 Q1	2012 Q4	2012 Q3
Revenue	$308.3K	$552.0K	$471.9K
YoY Change	-56.4%	57.73%	124.71%
Cost Of Revenue	$1.040M	$840.0K	$970.0K
YoY Change	-37.72%	-4.55%	42.65%
Gross Profit	-$730.0K	-$290.0K	-$500.0K
YoY Change	-23.96%	-44.23%	6.38%
Gross Profit Margin	-236.75%	-52.53%	-105.96%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development	$449.8K	$430.0K	$369.4K
YoY Change	-29.32%	38.71%	8.64%
% of Gross Profit
Depreciation & Amortization	$6.075K	$0.00	$10.00K
YoY Change	-41.14%	-100.0%	0.0%
% of Gross Profit
Operating Expenses	$1.487M	$430.0K	$1.342M
YoY Change	-35.47%	38.71%	294.61%
Operating Profit	-$1.179M	-$612.8K	-$869.8K
YoY Change	-27.04%	-26.55%	7.06%
Interest Expense	$10.00K	$10.00K	$0.00
YoY Change	0.0%	0.0%	-100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$1.170M	-$710.0K	-$866.5K
YoY Change	-26.42%	-13.41%	8.31%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$1.170M	-$604.2K	-$866.5K
YoY Change	-27.22%	-26.83%	8.06%
Net Earnings / Revenue	-379.44%	-109.46%	-183.62%
Basic Earnings Per Share
Diluted Earnings Per Share	-$50.61K	-$31.32K	-$43.48K
COMMON SHARES
Basic Shares Outstanding	23.11M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q1	2012 Q4	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.18M	$13.44M	$9.020M
YoY Change	-20.9%	267.21%	91.1%
Cash & Equivalents	$5.098M	$8.390M	$7.966M
Short-Term Investments	$5.080M	$5.050M	$1.050M
Other Short-Term Assets	$80.00K	$200.0K	$70.00K
YoY Change	-11.11%	17.65%	-41.67%
Inventory
Prepaid Expenses
Receivables	$860.4K	$688.3K	$570.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$11.12M	$14.33M	$9.660M
YoY Change	-19.15%	232.56%	87.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$101.5K	$59.04K	$70.00K
YoY Change	69.23%	-26.2%	-22.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$33.57K	$20.00K	$20.00K
YoY Change	67.84%	0.0%	0.0%
Total Long-Term Assets	$135.1K	$81.65K	$90.00K
YoY Change	50.11%	-25.78%	-25.0%
TOTAL ASSETS
Total Short-Term Assets	$11.12M	$14.33M	$9.660M
Total Long-Term Assets	$135.1K	$81.65K	$90.00K
Total Assets	$11.25M	$14.42M	$9.750M
YoY Change	-18.7%	226.13%	85.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$138.4K	$72.27K	$140.0K
YoY Change	-18.6%	-27.73%	0.0%
Accrued Expenses	$201.5K	$145.1K	$120.0K
YoY Change	11.93%	-23.62%	20.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$396.1K	$242.4K	$340.0K
YoY Change	-26.65%	-21.81%	3.03%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$396.1K	$242.4K	$340.0K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$400.0K	$240.0K	$340.0K
YoY Change	-25.93%	-22.58%	3.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$94.47M	-$87.47M
YoY Change
Common Stock	$105.3M	$101.6M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.86M	$14.17M	$9.410M
YoY Change
Total Liabilities & Shareholders Equity	$11.25M	$14.42M	$9.750M
YoY Change	-18.7%	226.13%	85.36%

Cashflow Statement

Concept	2014 Q1	2012 Q4	2012 Q3
OPERATING ACTIVITIES
Net Income	-$1.170M	-$604.2K	-$866.5K
YoY Change	-27.22%	-26.83%	8.06%
Depreciation, Depletion And Amortization	$6.075K	$0.00	$10.00K
YoY Change	-41.14%	-100.0%	0.0%
Cash From Operating Activities	-$810.0K	-$850.0K	-$840.0K
YoY Change	44.64%	-19.05%	3.7%
INVESTING ACTIVITIES
Capital Expenditures	$43.25K	$0.00	-$10.00K
YoY Change	288.65%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$4.000M	$0.00
YoY Change		-640.54%
Cash From Investing Activities	-$40.00K	-$4.000M	-$10.00K
YoY Change	300.0%	-640.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$5.276M	$5.229M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	80.00K	5.280M	6.970M
YoY Change
NET CHANGE
Cash From Operating Activities	-810.0K	-850.0K	-840.0K
Cash From Investing Activities	-40.00K	-4.000M	-10.00K
Cash From Financing Activities	80.00K	5.280M	6.970M
Net Change In Cash	-770.0K	430.0K	6.120M
YoY Change	35.09%	-238.71%	-855.56%
FREE CASH FLOW
Cash From Operating Activities	-$810.0K	-$850.0K	-$840.0K
Capital Expenditures	$43.25K	$0.00	-$10.00K
Free Cash Flow	-$853.2K	-$850.0K	-$830.0K
YoY Change	49.4%	-19.05%	2.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0000793524
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23109665	shares
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2013Q2	dei	Entity Public Float EntityPublicFloat	73886802	USD
CY2013	dei	Entity Registrant Name EntityRegistrantName	RESEARCH FRONTIERS INC
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2012Q4	refr	Deposits And Other Assets Non Current DepositsAndOtherAssetsNonCurrent	22605	USD
CY2013Q4	refr	Deposits And Other Assets Non Current DepositsAndOtherAssetsNonCurrent	22605	USD
CY2012	refr	Warrants Issued To Investors During Period WarrantsIssuedToInvestorsDuringPeriod	747846	shares
CY2012Q3	refr	Warrants Issued To Investors During Period WarrantsIssuedToInvestorsDuringPeriod	117846	shares
CY2012Q3	refr	Warrants Issued To Investors During Period WarrantsIssuedToInvestorsDuringPeriod	380000	shares
CY2012Q4	refr	Warrants Issued To Investors During Period WarrantsIssuedToInvestorsDuringPeriod	250000	shares
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	72269	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	56603	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	688318	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	867162	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	145123	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	80725	USD
CY2012Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	23450	USD
CY2013Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4400	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1680045	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1725257	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	101642297	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	105184600	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2545060	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	873888	USD
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	719811	USD
CY2013Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1841000	USD
CY2012Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	424000	USD
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	92723	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	173921	USD
CY2013	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries		USD
CY2012	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries		USD
CY2011	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	70000	USD
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2860219	shares
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2630002	shares
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1973906	shares
CY2012Q4	us-gaap	Assets Assets	14415067	USD
CY2013Q4	us-gaap	Assets Assets	12032265	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	14333421	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	11945295	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2403364	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8390233	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5866123	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6957544	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	8400000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	5900000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2524110	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	5986869	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4554180	USD
CY2013Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	5600000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22646782	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23109665	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22646782	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23109665	shares
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	2265	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	2311	USD
CY2012Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	10691	USD
CY2013Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent		USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	25000	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	25000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	24700000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	25624000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	22516000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	23116000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	15000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	15000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	95000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	104000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	977000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	972000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1051000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1347000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	37000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	70000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	24700000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	25624000	USD
CY2013	us-gaap	Depreciation Depreciation	45212	USD
CY2012	us-gaap	Depreciation Depreciation	34963	USD
CY2011	us-gaap	Depreciation Depreciation	39857	USD
CY2012Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	5100000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	45212	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	34963	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	39857	USD
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.25
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.15
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.22
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2013Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2012Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2012Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2012Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	110621	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	75966	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5841268	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3995633	USD
CY2011	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3618635	USD
CY2013Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	5100000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5845087	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3676998	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4134068	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-613397	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-80064	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-67547	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2300	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	260042	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	354268	USD
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-116127	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-94544	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	107218	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5037	USD
CY2013	us-gaap	Investment Income Interest InvestmentIncomeInterest	38148	USD
CY2012	us-gaap	Investment Income Interest InvestmentIncomeInterest	33171	USD
CY2012Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5052921	USD
CY2013Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5076930	USD
CY2011	us-gaap	Investment Income Interest InvestmentIncomeInterest	29274	USD
CY2013	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	174320	USD
CY2012	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	4690	USD
CY2011	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	-16974	USD
CY2013	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2014-01-31
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14415067	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12032265	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	242392	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	162328	USD
CY2013	us-gaap	Licenses Revenue LicensesRevenue	2161359	USD
CY2012	us-gaap	Licenses Revenue LicensesRevenue	1957336	USD
CY2011	us-gaap	Licenses Revenue LicensesRevenue	845982	USD
CY2013Q1	us-gaap	Licenses Revenue LicensesRevenue	707231	USD
CY2013Q2	us-gaap	Licenses Revenue LicensesRevenue	521844	USD
CY2013Q3	us-gaap	Licenses Revenue LicensesRevenue	506692	USD
CY2013Q4	us-gaap	Licenses Revenue LicensesRevenue	425592	USD
CY2012Q1	us-gaap	Licenses Revenue LicensesRevenue	482578	USD
CY2012Q2	us-gaap	Licenses Revenue LicensesRevenue	450828	USD
CY2012Q3	us-gaap	Licenses Revenue LicensesRevenue	471886	USD
CY2012Q4	us-gaap	Licenses Revenue LicensesRevenue	552044	USD
CY2013	us-gaap	Nature Of Operations NatureOfOperations	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="text-align: justify"><font style="font-family: Times New Roman; font-size: 80%">(1)</font> <u style="font-family: Times New Roman; font-size: 80%">Business</u></p> <p style="text-align: justify">     <font style="font-family: Times New Roman; font-size: 80%">Research Frontiers Incorporated ("Research Frontiers" or the "Company") operates in a single business segment which is engaged in the development and marketing of technology and devices to control the flow of light. Such devices, often referred to as "light valves" or suspended particle devices (SPDs), use colloidal particles that are either incorporated within a liquid suspension or a film, which is usually enclosed between two sheets of glass or plastic having transparent, electrically conductive coatings on the facing surfaces thereof. At least one of the two sheets is transparent. SPD technology, made possible by a flexible light-control film invented by Research Frontiers, allows the user to instantly and precisely control the shading of glass/plastic manually or automatically. SPD technology has numerous product applications, including: SPD-Smart™ windows, sunshades, skylights and interior partitions for homes and buildings; automotive windows, sunroofs, sun-visors, sunshades, rear-view mirrors, instrument panels and navigation systems; aircraft windows; eyewear products; and flat panel displays for electronic products. SPD-Smart light control film is now being developed for, or used in, architectural, automotive, marine, aerospace and appliance applications.</font></p> <p style="font-family: Times New Roman; font-size: 80%; text-align: justify"> <font style="font-family: Times New Roman">    </font> The Company has historically utilized its cash, cash equivalents, short-term investments, and the proceeds from the sale of its investments to fund its research and development of SPD light valves, for marketing initiatives, and for other working capital purposes. The Company's working capital and capital requirements depend upon numerous factors, including the results of research and development activities, competitive and technological developments, the timing and cost of patent filings, and the development of new licensees and changes in the Company's relationships with its existing licensees. The degree of dependence of the Company's working capital requirements on each of the foregoing factors cannot be quantified; increased research and development activities and related costs would increase such requirements; the addition of new licensees may provide additional working capital or working capital requirements, and changes in relationships with existing licensees would have a favorable or negative impact depending upon the nature of such changes. There can be no assurance that expenditures will not exceed the anticipated amounts or that additional financing, if required, will be available when needed or, if available, that its terms will be favorable or acceptable to the Company. Eventual success of the Company and generation of positive cash flow will be dependent upon the commercialization of products using the Company's technology by the Company's licensees and payments of continuing royalties on account thereof. To date, the Company has not generated sufficient revenue from its licensees to fund its operations.</p> <!--EndFragment--></div> </div>
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	795294	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	12250500	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	65977	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-74545	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-3584538	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1267573	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3244859	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2679093	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3352584	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-5845087	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-3063601	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-4134068	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-1589184	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-779480	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-859954	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-2616469	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	-803339	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-789551	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-866464	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	-604247	USD
CY2013Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	175000	USD
CY2012Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	175000	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	8044594	USD
CY2012	us-gaap	Operating Expenses OperatingExpenses	5667505	USD
CY2011	us-gaap	Operating Expenses OperatingExpenses	5009324	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-5883235	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-3710169	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-4163342	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1597036	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-790636	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-869483	USD
CY2013Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2626080	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1434553	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-793041	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-869788	USD
CY2012Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-612787	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	163000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	186000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	180000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	174000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	168000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1294000	USD
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	187000	USD
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	200000	USD
CY2011	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	172000	USD
CY2013Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	58000000	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	361	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	359	USD
CY2012Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	4455	USD
CY2012Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	413719	USD
CY2012Q4	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	336750	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	50536	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11576	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12517	USD
CY2013	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	24009	USD
CY2012	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	3797865	USD
CY2011	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	2255056	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	201949	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	135080	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12250500	USD
CY2012Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1745549	USD
CY2012Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5229201	USD
CY2012Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5275750	USD
CY2013	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	795294	USD
CY2012	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	12250500	USD
CY2011	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	65977	USD
CY2013	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		USD
CY2012	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		USD
CY2011	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1000000	USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	822969	USD
CY2013	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	472819	USD
CY2011	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	26233	USD
CY2012	us-gaap	Professional Fees ProfessionalFees	61340	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1739086	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1789622	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	59041	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	64365	USD
CY2013	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties		USD
CY2012	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	224903	USD
CY2011	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties		USD
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	81198	USD
CY2012	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		USD
CY2011	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2203326	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1671872	USD
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1390689	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-87471887	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-93316974	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	2719380	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	878578	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	702837	USD
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.64	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0162	pure
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	750000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	611692	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.86
CY2013	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate		pure
CY2012Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	2.97
CY2012Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	2.97
CY2012Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	4.49
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	4107198	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	14172675	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	11869937	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	7472452	USD
CY2013	us-gaap	Stock Issued1 StockIssued1	27675	USD
CY2012	us-gaap	Stock Issued1 StockIssued1		USD
CY2011	us-gaap	Stock Issued1 StockIssued1	276750	USD
CY2012	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3739227	shares
CY2012Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	589227	shares
CY2012Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1900000	shares
CY2012Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1250000	shares
CY2012	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	12250500	USD
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2719380	USD
CY2012	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	878578	USD
CY2011	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	702837	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	822969	USD
CY2011	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	65977	USD
CY2013Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	972000	USD
CY2013	us-gaap	Tax Credit Carryforward Expiration Date TaxCreditCarryforwardExpirationDate	2033-12-31
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="text-align: justify"><font style="font-family: Times New Roman; font-size: 80%"><font style="font-family: Times New Roman">    </font> (i)</font> <u style="font-family: Times New Roman; font-size: 80%">Use of Estimates</u></p> <p style="font-family: Times New Roman; font-size: 80%; text-align: justify"> <font style="font-family: Times New Roman">    </font> The preparation of the Company's consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during this period. Actual results could differ from those estimates.</p> <!--EndFragment--></div> </div>
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	22946019	shares
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20125309	shares
CY2011	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	18538041	shares

Files In Submission

Name	View Source	Status
0001206774-14-000818-index-headers.html	Edgar Link	pending
0001206774-14-000818-index.html	Edgar Link	pending
0001206774-14-000818.txt	Edgar Link	pending
0001206774-14-000818-xbrl.zip	Edgar Link	pending
exhibit10-5_5.htm	Edgar Link	pending
exhibit10_1c.htm	Edgar Link	pending
exhibit23.htm	Edgar Link	pending
exhibit31-1.htm	Edgar Link	pending
exhibit31-2.htm	Edgar Link	pending
exhibit32-1.htm	Edgar Link	pending
exhibit32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
refr-20131231.xml	Edgar Link	completed
refr-20131231.xsd	Edgar Link	pending
refr-20131231_cal.xml	Edgar Link	unprocessable
refr-20131231_def.xml	Edgar Link	unprocessable
refr-20131231_lab.xml	Edgar Link	unprocessable
refr-20131231_pre.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
research_10k.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$REFR
RESEARCH FRONTIERS INC Stock $refr

2014 Q1 Form 10-K Financial Statement

#000120677414000818 Filed on March 10, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REFR RESEARCH FRONTIERS INC Stock $refr

2014 Q1 Form 10-K Financial Statement

#000120677414000818 Filed on March 10, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REFR
RESEARCH FRONTIERS INC Stock $refr